Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Acute Biphenotypic Leukemia

Clinical trial condition

Refractory Acute Biphenotypic Leukemia

Explore clinical trials studying Refractory Acute Biphenotypic Leukemia. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Acute Biphenotypic Leukemia trial results

Recruiting

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

NCT04797767

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

NCT04975919

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details